{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:02:30Z","timestamp":1789383750864,"version":"build-2803163510"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"DOI":"10.1038\/s41575-026-01258-w","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:48:02Z","timestamp":1789375682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug\u2013microbiome\u2013host interactions:\u00a0antimicrobial effects of non-antibiotic compounds"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-992X","authenticated-orcid":false,"given":"Jacobo","family":"de la Cuesta-Zuluaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-8640","authenticated-orcid":false,"given":"Kiran R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-4762","authenticated-orcid":false,"given":"Lisa","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"1258_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg, G. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8, 103 (2020).","journal-title":"Microbiome"},{"key":"1258_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM De Vos","year":"2022","unstructured":"De Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020\u20131032 (2022).","journal-title":"Gut"},{"key":"1258_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41576-025-00849-8","volume":"27","author":"P Ferretti","year":"2026","unstructured":"Ferretti, P., Johnson, K., Priya, S. & Blekhman, R. Genomics of host\u2013microbiome interactions in humans. Nat. Rev. Genet. 27, 62\u201380 (2026).","journal-title":"Nat. Rev. Genet."},{"key":"1258_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41586-023-06893-w","volume":"625","author":"DV Zhernakova","year":"2024","unstructured":"Zhernakova, D. V. et al. Host genetic regulation of human gut microbial structural variation. Nature 625, 813\u2013821 (2024).","journal-title":"Nature"},{"key":"1258_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1258_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross, F. C. et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat. Rev. Microbiol. 22, 671\u2013686 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41575-025-01077-5","volume":"22","author":"Y Sanz","year":"2025","unstructured":"Sanz, Y. et al. The gut microbiome connects nutrition and human health. Nat. Rev. Gastroenterol. Hepatol. 22, 534\u2013555 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1258_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2519697","volume":"17","author":"J Schumacher","year":"2025","unstructured":"Schumacher, J. et al. Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model. Gut Microbes 17, 2519697 (2025).","journal-title":"Gut Microbes"},{"key":"1258_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41575-025-01092-6","volume":"22","author":"JE Brinck","year":"2025","unstructured":"Brinck, J. E. et al. Intestinal pH: a major driver of human gut microbiota composition and metabolism. Nat. Rev. Gastroenterol. Hepatol. 22, 639\u2013656 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1258_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature 587, 448\u2013454 (2020).","journal-title":"Nature"},{"key":"1258_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.chom.2024.05.002","volume":"32","author":"S Woelfel","year":"2024","unstructured":"Woelfel, S., Silva, M. S. & Stecher, B. Intestinal colonization resistance in the context of environmental, host, and microbial determinants. Cell Host Microbe 32, 820\u2013836 (2024).","journal-title":"Cell Host Microbe"},{"key":"1258_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202010116","volume":"17","author":"M Zimmermann","year":"2021","unstructured":"Zimmermann, M., Patil, K. R., Typas, A. & Maier, L. Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol. Syst. Biol. 17, e10116 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"1258_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","volume":"14","author":"P Spanogiannopoulos","year":"2016","unstructured":"Spanogiannopoulos, P., Bess, E. N., Carmody, R. N. & Turnbaugh, P. J. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273\u2013287 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR15","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","volume":"69","author":"RK Weersma","year":"2020","unstructured":"Weersma, R. K., Zhernakova, A. & Fu, J. Interaction between drugs and the gut microbiome. Gut 69, 1510\u20131519 (2020).","journal-title":"Gut"},{"key":"1258_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","volume":"604","author":"R Gacesa","year":"2022","unstructured":"Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732\u2013739 (2022).","journal-title":"Nature"},{"key":"1258_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.gastro.2022.06.070","volume":"163","author":"N Nagata","year":"2022","unstructured":"Nagata, N. et al. Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome. Gastroenterology 163, 1038\u20131052 (2022).","journal-title":"Gastroenterology"},{"key":"1258_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00541-25","volume":"10","author":"O Aasmets","year":"2025","unstructured":"Aasmets, O. et al. A hidden confounder for microbiome studies: medications used years before sample collection. mSystems 10, e00541-25 (2025).","journal-title":"mSystems"},{"key":"1258_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/gut.16.4.318","volume":"16","author":"MJ Hill","year":"1975","unstructured":"Hill, M. J. & Drasar, B. S. The normal colonic bacterial flora. Gut 16, 318\u2013323 (1975).","journal-title":"Gut"},{"key":"1258_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"1258_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41579-022-00681-5","volume":"20","author":"AE Lindell","year":"2022","unstructured":"Lindell, A. E., Zimmermann-Kogadeeva, M. & Patil, K. R. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat. Rev. Microbiol. 20, 431\u2013443 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR22","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1038\/s41564-025-02182-6","volume":"10","author":"I Roux","year":"2025","unstructured":"Roux, I. et al. Industrial and agricultural chemicals exhibit antimicrobial activity against human gut bacteria in vitro. Nat. Microbiol. 10, 3107\u20133121 (2025).","journal-title":"Nat. Microbiol."},{"key":"1258_CR23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41564-025-02032-5","volume":"10","author":"AE Lindell","year":"2025","unstructured":"Lindell, A. E. et al. Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances. Nat. Microbiol. 10, 1630\u20131647 (2025).","journal-title":"Nat. Microbiol."},{"key":"1258_CR24","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.cell.2024.08.038","volume":"187","author":"EJ Culp","year":"2024","unstructured":"Culp, E. J., Nelson, N. T., Verdegaal, A. A. & Goodman, A. L. Microbial transformation of dietary xenobiotics shapes gut microbiome composition. Cell 187, 6327\u20136345.e20 (2024).","journal-title":"Cell"},{"key":"1258_CR25","doi-asserted-by":"publisher","first-page":"ofad195","DOI":"10.1093\/ofid\/ofad195","volume":"10","author":"A Heirali","year":"2023","unstructured":"Heirali, A., Moossavi, S., Arrieta, M. C. & Coburn, B. Principles and terminology for host\u2013microbiome\u2013drug interactions. Open. Forum Infect. Dis. 10, ofad195 (2023).","journal-title":"Open. Forum Infect. Dis."},{"key":"1258_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao, Q., Chen, Y., Huang, W., Zhou, H. & Zhang, W. Drug-microbiota interactions: an emerging priority for precision medicine. Sig. Transduct. Target. Ther. 8, 386 (2023).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1258_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-pharmtox-022724-100847","volume":"65","author":"KR Trepka","year":"2025","unstructured":"Trepka, K. R., Olson, C. A., Upadhyay, V., Zhang, C. & Turnbaugh, P. J. Pharma[e]cology: how the gut microbiome contributes to variations in drug response. Annu. Rev. Pharmacol. Toxicol. 65, 355\u2013373 (2025).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1258_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41586-025-09217-2","volume":"644","author":"A Grie\u00dfhammer","year":"2025","unstructured":"Grie\u00dfhammer, A. et al. Non-antibiotics disrupt colonization resistance against enteropathogens. Nature 644, 497\u2013505 (2025).","journal-title":"Nature"},{"key":"1258_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41564-023-01581-x","volume":"9","author":"D Ricaurte","year":"2024","unstructured":"Ricaurte, D. et al. High-throughput transcriptomics of 409 bacteria\u2013drug pairs reveals drivers of gut microbiota perturbation. Nat. Microbiol. 9, 561\u2013575 (2024).","journal-title":"Nat. Microbiol."},{"key":"1258_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462\u2013467 (2019).","journal-title":"Nature"},{"key":"1258_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","volume":"597","author":"M Kl\u00fcnemann","year":"2021","unstructured":"Kl\u00fcnemann, M. et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 597, 533\u2013538 (2021).","journal-title":"Nature"},{"key":"1258_CR32","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1016\/j.cell.2024.08.037","volume":"187","author":"S Garcia-Santamarina","year":"2024","unstructured":"Garcia-Santamarina, S. et al. Emergence of community behaviors in the gut microbiota upon drug treatment. Cell 187, 6346\u20136357.e20 (2024).","journal-title":"Cell"},{"key":"1258_CR33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s44320-025-00130-4","volume":"21","author":"S Kamrad","year":"2025","unstructured":"Kamrad, S., Davis, T. F. & Patil, K. R. Impact of drugs and environmental contaminants on amine production by gut bacteria. Mol. Syst. Biol. 21, 1351\u20131370 (2025).","journal-title":"Mol. Syst. Biol."},{"key":"1258_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41575-024-00893-5","volume":"21","author":"K Whelan","year":"2024","unstructured":"Whelan, K., Bancil, A. S., Lindsay, J. O. & Chassaing, B. Ultra-processed foods and food additives in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 21, 406\u2013427 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1258_CR35","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s00394-019-02161-8","volume":"59","author":"K Gerasimidis","year":"2020","unstructured":"Gerasimidis, K. et al. The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity. Eur. J. Nutr. 59, 3213\u20133230 (2020).","journal-title":"Eur. J. Nutr."},{"key":"1258_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s44320-026-00225-6","volume":"22","author":"S Blasche","year":"2026","unstructured":"Blasche, S. et al. Common xenobiotics modulate gut microbial responses to low-calorie sweeteners in vitro. Mol. Syst. Biol.22, 1453\u20131473 (2026).","journal-title":"Mol. Syst. Biol."},{"key":"1258_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59747-6","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Mapping pesticide-induced metabolic alterations in human gut bacteria. Nat. Commun. 16, 4355 (2025).","journal-title":"Nat. Commun."},{"key":"1258_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55\u201360 (2012).","journal-title":"Nature"},{"key":"1258_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262\u2013266 (2015).","journal-title":"Nature"},{"key":"1258_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850\u2013858 (2017).","journal-title":"Nat. Med."},{"key":"1258_CR41","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560\u2013564 (2016).","journal-title":"Science"},{"key":"1258_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565\u2013569 (2016).","journal-title":"Science"},{"key":"1258_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila, A. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 11, 362 (2020).","journal-title":"Nat. Commun."},{"key":"1258_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","volume":"600","author":"SK Forslund","year":"2021","unstructured":"Forslund, S. K. et al. Combinatorial, additive and dose-dependent drug\u2013microbiome associations. Nature 600, 500\u2013505 (2021).","journal-title":"Nature"},{"key":"1258_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71571-4","volume":"14","author":"A Larsson","year":"2024","unstructured":"Larsson, A. et al. New connections of medication use and polypharmacy with the gut microbiota composition and functional potential in a large population. Sci. Rep. 14, 23723 (2024).","journal-title":"Sci. Rep."},{"key":"1258_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/14737159.2021.1952075","volume":"21","author":"Q Le Bastard","year":"2021","unstructured":"Le Bastard, Q., Berthelot, L., Soulillou, J.-P. & Montassier, E. Impact of non-antibiotic drugs on the human intestinal microbiome. Expert. Rev. Mol. Diagn. 21, 911\u2013924 (2021).","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"1258_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/apt.14451","volume":"47","author":"Q Le Bastard","year":"2018","unstructured":"Le Bastard, Q. et al. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment. Pharmacol. Ther. 47, 332\u2013345 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1258_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1053\/j.gastro.2021.11.006","volume":"162","author":"B Chassaing","year":"2022","unstructured":"Chassaing, B. et al. Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome. Gastroenterology 162, 743\u2013756 (2022).","journal-title":"Gastroenterology"},{"key":"1258_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nature13793","volume":"514","author":"J Suez","year":"2014","unstructured":"Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181\u2013186 (2014).","journal-title":"Nature"},{"key":"1258_CR50","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1016\/j.cell.2022.07.016","volume":"185","author":"J Suez","year":"2022","unstructured":"Suez, J. et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell 185, 3307\u20133328.e19 (2022).","journal-title":"Cell"},{"key":"1258_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00976-w","volume":"9","author":"J Serrano","year":"2021","unstructured":"Serrano, J. et al. High-dose saccharin supplementation does not induce gut microbiota changes or glucose intolerance in healthy humans and mice. Microbiome 9, 11 (2021).","journal-title":"Microbiome"},{"key":"1258_CR52","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.3390\/nu12113408","volume":"12","author":"SY Ahmad","year":"2020","unstructured":"Ahmad, S. Y., Friel, J. & Mackay, D. The effects of non-nutritive artificial sweeteners, aspartame and sucralose, on the gut microbiome in healthy adults: secondary outcomes of a randomized double-blinded crossover clinical trial. Nutrients 12, 3408 (2020).","journal-title":"Nutrients"},{"key":"1258_CR53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1017\/S0007114519001570","volume":"122","author":"P Thomson","year":"2019","unstructured":"Thomson, P., Santiba\u00f1ez, R., Aguirre, C., Galgani, J. E. & Garrido, D. Short-term impact of sucralose consumption on the metabolic response and gut microbiome of healthy adults. Br. J. Nutr. 122, 856\u2013862 (2019).","journal-title":"Br. J. Nutr."},{"key":"1258_CR54","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41396-023-01450-9","volume":"17","author":"R Matsuzaki","year":"2023","unstructured":"Matsuzaki, R. et al. Pesticide exposure and the microbiota\u2013gut\u2013brain axis. ISME J. 17, 1153\u20131166 (2023).","journal-title":"ISME J."},{"key":"1258_CR55","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.3390\/ijerph18115510","volume":"18","author":"F Giamb\u00f2","year":"2021","unstructured":"Giamb\u00f2, F., Teodoro, M., Costa, C. & Fenga, C. Toxicology and microbiota: how do pesticides influence gut microbiota? A review. Int. J. Environ. Res. Public Health 18, 5510 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1258_CR56","doi-asserted-by":"publisher","first-page":"2187578","DOI":"10.1080\/19490976.2023.2187578","volume":"15","author":"T Sharma","year":"2023","unstructured":"Sharma, T., Sirpu Natesh, N., Pothuraju, R., Batra, S. K. & Rachagani, S. Gut microbiota: a non-target victim of pesticide-induced toxicity. Gut Microbes 15, 2187578 (2023).","journal-title":"Gut Microbes"},{"key":"1258_CR57","doi-asserted-by":"publisher","first-page":"10517","DOI":"10.1021\/acs.jafc.0c04678","volume":"68","author":"Z Meng","year":"2020","unstructured":"Meng, Z. et al. Gut microbiota: a key factor in the host health effects induced by pesticide exposure? J. Agric. Food Chem. 68, 10517\u201310531 (2020).","journal-title":"J. Agric. Food Chem."},{"key":"1258_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1223120","volume":"14","author":"MFB Gois","year":"2023","unstructured":"Gois, M. F. B. et al. Impact of occupational pesticide exposure on the human gut microbiome. Front. Microbiol. 14, 1223120 (2023).","journal-title":"Front. Microbiol."},{"key":"1258_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48739-7","volume":"15","author":"F De Filippis","year":"2024","unstructured":"De Filippis, F. et al. Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome. Nat. Commun. 15, 4482 (2024).","journal-title":"Nat. Commun."},{"key":"1258_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijerph20010213","volume":"20","author":"J Ueyama","year":"2023","unstructured":"Ueyama, J. et al. Effects of pesticide intake on gut microbiota and metabolites in healthy adults. Int. J. Environ. Res. Public Health 20, 213 (2023).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1258_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12940-024-01078-y","volume":"23","author":"K Zhang","year":"2024","unstructured":"Zhang, K. et al. Ambient long-term exposure to organophosphorus pesticides and the human gut microbiome: an observational study. Environ. Health 23, 41 (2024).","journal-title":"Environ. Health"},{"key":"1258_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.adk7368","volume":"384","author":"MN Guillen","year":"2024","unstructured":"Guillen, M. N., Li, C., Rosener, B. & Mitchell, A. Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science 384, 93\u2013100 (2024).","journal-title":"Science"},{"key":"1258_CR63","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1073\/pnas.1511751112","volume":"112","author":"MA Farha","year":"2015","unstructured":"Farha, M. A. et al. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc. Natl Acad. Sci. USA 112, 11048\u201311053 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1258_CR64","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1021\/acsinfecdis.4c00495","volume":"10","author":"Q Meng","year":"2024","unstructured":"Meng, Q. et al. Repurposing benzbromarone as an antibacterial agent against Gram-positive bacteria. ACS Infect. Dis. 10, 4208\u20134221 (2024).","journal-title":"ACS Infect. Dis."},{"key":"1258_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389\u2013395 (2002).","journal-title":"Nature"},{"key":"1258_CR66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/ph14090915","volume":"14","author":"M Caldara","year":"2021","unstructured":"Caldara, M. & Marmiroli, N. Antimicrobial properties of antidepressants and antipsychotics \u2014 possibilities and implications. Pharmaceuticals 14, 915 (2021).","journal-title":"Pharmaceuticals"},{"key":"1258_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s43705-022-00147-y","volume":"2","author":"J Lu","year":"2022","unstructured":"Lu, J., Ding, P., Wang, Y. & Guo, J. Antidepressants promote the spread of extracellular antibiotic resistance genes via transformation. ISME Commun. 2, 63 (2022).","journal-title":"ISME Commun."},{"key":"1258_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","volume":"4","author":"MAT Blaskovich","year":"2021","unstructured":"Blaskovich, M. A. T. et al. The antimicrobial potential of cannabidiol. Commun. Biol. 4, 7 (2021).","journal-title":"Commun. Biol."},{"key":"1258_CR69","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2672.2004.02275.x","volume":"97","author":"DJ Fitzgerald","year":"2004","unstructured":"Fitzgerald, D. J. et al. Mode of antimicrobial action of vanillin against Escherichia coli, Lactobacillus plantarum and Listeria innocua. J. Appl. Microbiol. 97, 104\u2013113 (2004).","journal-title":"J. Appl. Microbiol."},{"key":"1258_CR70","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1021\/acsomega.5c04177","volume":"10","author":"M Panella","year":"2025","unstructured":"Panella, M. et al. Membrane-modifying effects of perfluoroalkyl substances in model bacterial membranes. ACS Omega 10, 39884\u201339897 (2025).","journal-title":"ACS Omega"},{"key":"1258_CR71","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.chembiol.2014.02.009","volume":"21","author":"Z Yin","year":"2014","unstructured":"Yin, Z. et al. DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chem. Biol. 21, 481\u2013487 (2014).","journal-title":"Chem. Biol."},{"key":"1258_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111625","volume":"41","author":"KD LaCourse","year":"2022","unstructured":"LaCourse, K. D. et al. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. Cell Rep. 41, 111625 (2022).","journal-title":"Cell Rep."},{"key":"1258_CR73","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41564-022-01226-5","volume":"7","author":"P Spanogiannopoulos","year":"2022","unstructured":"Spanogiannopoulos, P. et al. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat. Microbiol. 7, 1605\u20131620 (2022).","journal-title":"Nat. Microbiol."},{"key":"1258_CR74","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s44321-025-00219-1","volume":"17","author":"R de Dios","year":"2025","unstructured":"de Dios, R. et al. Saccharin disrupts bacterial cell envelope stability and interferes with DNA replication dynamics. EMBO Mol. Med. 17, 993\u20131017 (2025).","journal-title":"EMBO Mol. Med."},{"key":"1258_CR75","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1093\/nar\/gkt084","volume":"41","author":"Y-S Lo","year":"2013","unstructured":"Lo, Y.-S., Tseng, W.-H., Chuang, C.-Y. & Hou, M.-H. The structural basis of actinomycin D-binding induces nucleotide flipping out, a sharp bend and a left-handed twist in CGG triplet repeats. Nucleic Acids Res. 41, 4284\u20134294 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1258_CR76","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.csbj.2020.04.014","volume":"18","author":"R Aviner","year":"2020","unstructured":"Aviner, R. The science of puromycin: from studies of ribosome function to applications in biotechnology. Computat. Struct. Biotechnol. J. 18, 1074\u20131083 (2020).","journal-title":"Computat. Struct. Biotechnol. J."},{"key":"1258_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu0151","volume":"11","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y., Xu, C., Chen, X., Jin, H. & Li, H. Structural basis for hygromycin B inhibition of yeast pseudouridine-deficient ribosomes. Sci. Adv. 11, eadu0151 (2025).","journal-title":"Sci. Adv."},{"key":"1258_CR78","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1093\/nar\/gkab532","volume":"49","author":"KT Powers","year":"2021","unstructured":"Powers, K. T. et al. Blasticidin S inhibits mammalian translation and enhances production of protein encoded by nonsense mRNA. Nucleic Acids Res. 49, 7665\u20137679 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1258_CR79","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jac\/dkac025","volume":"77","author":"M Miller","year":"2022","unstructured":"Miller, M. & Singer, M. Do antibiotics cause mitochondrial and immune cell dysfunction? A literature review. J. Antimicrob. Chemother. 77, 1218\u20131227 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"1258_CR80","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.chom.2020.12.008","volume":"29","author":"RR Nayak","year":"2021","unstructured":"Nayak, R. R. et al. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host Microbe 29, 362\u2013377.e11 (2021).","journal-title":"Cell Host Microbe"},{"key":"1258_CR81","doi-asserted-by":"publisher","first-page":"2263935","DOI":"10.1080\/19490976.2023.2263935","volume":"15","author":"L Walsh","year":"2023","unstructured":"Walsh, L., Hill, C. & Ross, R. P. Impact of glyphosate (Roundup) on the composition and functionality of the gut microbiome. Gut Microbes 15, 2263935 (2023).","journal-title":"Gut Microbes"},{"key":"1258_CR82","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s42003-023-04639-y","volume":"6","author":"S Bose","year":"2023","unstructured":"Bose, S. et al. Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor. Commun. Biol. 6, 360 (2023).","journal-title":"Commun. Biol."},{"key":"1258_CR83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1023216301165","volume":"19","author":"E Yilmaz","year":"2003","unstructured":"Yilmaz, E. Orlistat-induced molecular bio-imprinting of microbial lipase. World J. Microbiol. Biotechnol. 19, 161\u2013165 (2003).","journal-title":"World J. Microbiol. Biotechnol."},{"key":"1258_CR84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.orcp.2023.08.005","volume":"17","author":"Y Uehira","year":"2023","unstructured":"Uehira, Y. et al. Impact of the lipase inhibitor orlistat on the human gut microbiota. Obes. Res. Clin. Pract. 17, 411\u2013420 (2023).","journal-title":"Obes. Res. Clin. Pract."},{"key":"1258_CR85","doi-asserted-by":"publisher","first-page":"e01506","DOI":"10.1128\/mbio.01506-24","volume":"15","author":"HA Brown","year":"2024","unstructured":"Brown, H. A. et al. Acarbose impairs gut Bacteroides growth by targeting intracellular glucosidases. mBio 15, e01506-24 (2024).","journal-title":"mBio"},{"key":"1258_CR86","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/s41564-019-0540-4","volume":"4","author":"TC Fung","year":"2019","unstructured":"Fung, T. C. et al. Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut. Nat. Microbiol. 4, 2064\u20132073 (2019).","journal-title":"Nat. Microbiol."},{"key":"1258_CR87","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/jac\/dkr258","volume":"66","author":"JA Bohnert","year":"2011","unstructured":"Bohnert, J. A., Szymaniak-Vits, M., Schuster, S. & Kern, W. V. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. J. Antimicrob. Chemother. 66, 2057\u20132060 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"1258_CR88","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.chom.2024.05.009","volume":"32","author":"J de la Cuesta-Zuluaga","year":"2024","unstructured":"de la Cuesta-Zuluaga, J., Boldt, L. & Maier, L. Response, resistance, and recovery of gut bacteria to human-targeted drug exposure. Cell Host Microbe 32, 786\u2013793 (2024).","journal-title":"Cell Host Microbe"},{"key":"1258_CR89","doi-asserted-by":"publisher","first-page":"e00151","DOI":"10.1128\/mmbr.00151-22","volume":"88","author":"S Bouillet","year":"2024","unstructured":"Bouillet, S., Bauer, T. S. & Gottesman, S. RpoS and the bacterial general stress response. Microbiol. Mol. Biol. Rev. 88, e00151-22 (2024).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1258_CR90","doi-asserted-by":"publisher","first-page":"30229","DOI":"10.1074\/jbc.R114.572990","volume":"289","author":"C Pandya","year":"2014","unstructured":"Pandya, C., Farelli, J. D., Dunaway-Mariano, D. & Allen, K. N. Enzyme promiscuity: engine of evolutionary innovation. J. Biol. Chem. 289, 30229\u201330236 (2014).","journal-title":"J. Biol. Chem."},{"key":"1258_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00806-z","volume":"8","author":"L Li","year":"2020","unstructured":"Li, L. et al. RapidAIM: a culture- and metaproteomics-based rapid assay of individual microbiome responses to drugs. Microbiome 8, 33 (2020).","journal-title":"Microbiome"},{"key":"1258_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05184-7","volume":"9","author":"MA Jackson","year":"2018","unstructured":"Jackson, M. A. et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat. Commun. 9, 2655 (2018).","journal-title":"Nat. Commun."},{"key":"1258_CR93","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cll.2014.08.008","volume":"34","author":"DE Freedberg","year":"2014","unstructured":"Freedberg, D. E., Lebwohl, B. & Abrams, J. A. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin. Lab. Med. 34, 771\u2013785 (2014).","journal-title":"Clin. Lab. Med."},{"key":"1258_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0312-4","volume":"5","author":"JA Caparr\u00f3s-Mart\u00edn","year":"2017","unstructured":"Caparr\u00f3s-Mart\u00edn, J. A. et al. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome 5, 95 (2017).","journal-title":"Microbiome"},{"key":"1258_CR95","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/MIB.0000000000000332","volume":"21","author":"EY Huang","year":"2015","unstructured":"Huang, E. Y. et al. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflamm. Bowel Dis. 21, 963\u2013972 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"1258_CR96","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000522039","volume":"103","author":"H Okafuji","year":"2022","unstructured":"Okafuji, H. et al. Oral corticosteroids impair mucin production and alter the posttransplantation microbiota in the gut. Digestion 103, 269\u2013286 (2022).","journal-title":"Digestion"},{"key":"1258_CR97","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1038\/s41564-024-01853-0","volume":"9","author":"FC Pereira","year":"2024","unstructured":"Pereira, F. C. et al. The Parkinson\u2019s disease drug entacapone disrupts gut microbiome homeostasis via iron sequestration. Nat. Microbiol. 9, 3165\u20133183 (2024).","journal-title":"Nat. Microbiol."},{"key":"1258_CR98","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41586-025-09273-8","volume":"644","author":"A Kumar","year":"2025","unstructured":"Kumar, A. et al. Identification of medication-microbiome interactions that affect gut infection. Nature 644, 506\u2013515 (2025).","journal-title":"Nature"},{"key":"1258_CR99","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/metabo12020171","volume":"12","author":"T Kralj","year":"2022","unstructured":"Kralj, T. et al. Multi-omic analysis to characterize metabolic adaptation of the E. coli lipidome in response to environmental stress. Metabolites 12, 171 (2022).","journal-title":"Metabolites"},{"key":"1258_CR100","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12275-023-00031-x","volume":"61","author":"S Moon","year":"2023","unstructured":"Moon, S. et al. Temperature matters: bacterial response to temperature change. J. Microbiol. 61, 343\u2013357 (2023).","journal-title":"J. Microbiol."},{"key":"1258_CR101","doi-asserted-by":"publisher","first-page":"e00707","DOI":"10.1128\/msystems.00707-21","volume":"6","author":"KE Huus","year":"2021","unstructured":"Huus, K. E. & Ley, R. E. Blowing hot and cold: body temperature and the microbiome. mSystems 6, e00707-21\u00a0(2021).","journal-title":"mSystems"},{"key":"1258_CR102","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1046\/j.1472-765X.2002.01109.x","volume":"34","author":"G Huys","year":"2002","unstructured":"Huys, G., D\u2019Haene, K. & Swings, J. Influence of the culture medium on antibiotic susceptibility testing of food-associated lactic acid bacteria with the agar overlay disc diffusion method. Lett. Appl. Microbiol. 34, 402\u2013406 (2002).","journal-title":"Lett. Appl. Microbiol."},{"key":"1258_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.118961","volume":"302","author":"C Joly Condette","year":"2022","unstructured":"Joly Condette, C. et al. Effect of daily co-exposure to inulin and chlorpyrifos on selected microbiota endpoints in the SHIME model. Environ. Pollut. 302, 118961 (2022).","journal-title":"Environ. Pollut."},{"key":"1258_CR104","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.1211037","volume":"334","author":"D Nguyen","year":"2011","unstructured":"Nguyen, D. et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334, 982\u2013986 (2011).","journal-title":"Science"},{"key":"1258_CR105","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41579-023-00969-0","volume":"22","author":"G McCallum","year":"2024","unstructured":"McCallum, G. & Tropini, C. The gut microbiota and its biogeography. Nat. Rev. Microbiol. 22, 105\u2013118 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR106","doi-asserted-by":"publisher","unstructured":"van den Berg, N. I. et al. Emergent survival and extinction of species within gut bacterial communities. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.04.29.591619 (2024).","DOI":"10.1101\/2024.04.29.591619"},{"key":"1258_CR107","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1016\/j.cell.2025.10.038","volume":"188","author":"H Shi","year":"2025","unstructured":"Shi, H. et al. Nutrient competition predicts gut microbiome restructuring under drug perturbations. Cell 188, 6971\u20136986.e14 (2025).","journal-title":"Cell"},{"key":"1258_CR108","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41559-026-03030-4","volume":"10","author":"S Kamrad","year":"2026","unstructured":"Kamrad, S. et al. Interspecies interactions drive bacterial proteome reorganization and emergent metabolism. Nat. Ecol. Evol. 10, 1127\u20131144 (2026).","journal-title":"Nat. Ecol. Evol."},{"key":"1258_CR109","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41564-022-01304-8","volume":"8","author":"S Kamrad","year":"2023","unstructured":"Kamrad, S. et al. Metabolic heterogeneity and cross-feeding within isogenic yeast populations captured by DILAC. Nat. Microbiol. 8, 441\u2013454 (2023).","journal-title":"Nat. Microbiol."},{"key":"1258_CR110","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s42255-022-00656-z","volume":"4","author":"SJ Wolfson","year":"2022","unstructured":"Wolfson, S. J. et al. Bacterial hydrogen sulfide drives cryptic redox chemistry in gut microbial communities. Nat. Metab. 4, 1260\u20131270 (2022).","journal-title":"Nat. Metab."},{"key":"1258_CR111","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","volume":"181","author":"B Javdan","year":"2020","unstructured":"Javdan, B. et al. Personalized mapping of drug metabolism by the human gut microbiome. Cell 181, 1661\u20131679.e22 (2020).","journal-title":"Cell"},{"key":"1258_CR112","volume":"6","author":"A Gomez Lumbreras","year":"2022","unstructured":"Gomez Lumbreras, A. et al. Shared decision-making for drug\u2013drug interactions: formative evaluation of an anticoagulant drug interaction. J. Med. Internet Res. Form. Res. 6, e40018 (2022).","journal-title":"J. Med. Internet Res. Form. Res."},{"key":"1258_CR113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1503\/cmaj.120951","volume":"185","author":"DG Bailey","year":"2013","unstructured":"Bailey, D. G., Dresser, G. & Arnold, J. M. O. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Can. Med. Assoc. J. 185, 309\u2013316 (2013).","journal-title":"Can. Med. Assoc. J."},{"key":"1258_CR114","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","volume":"559","author":"AR Brochado","year":"2018","unstructured":"Brochado, A. R. et al. Species-specific activity of antibacterial drug combinations. Nature 559, 259\u2013263 (2018).","journal-title":"Nature"},{"key":"1258_CR115","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41579-022-00768-z","volume":"20","author":"C Martino","year":"2022","unstructured":"Martino, C. et al. Microbiota succession throughout life from cradle to the grave. Nat. Rev. Microbiol. 20, 707\u2013720 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR116","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41575-021-00452-2","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi, H., Rao, M. C. & Chang, E. B. Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism. Nat. Rev. Gastroenterol. Hepatol. 18, 679\u2013689 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1258_CR117","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.coemr.2025.100571","volume":"38","author":"M Zommiti","year":"2025","unstructured":"Zommiti, M. & Feuilloley, M. G. J. Sex hormones\u2013gut microbiome axis: an update of what is known so far. Curr. Opin. Endocr. Metab. Res. 38, 100571 (2025).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"1258_CR118","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Besten","year":"2013","unstructured":"Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325\u20132340 (2013).","journal-title":"J. Lipid Res."},{"key":"1258_CR119","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fmed.2017.00163","volume":"4","author":"V Urdaneta","year":"2017","unstructured":"Urdaneta, V. & Casades\u00fas, J. Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts. Front. Med. 4, 163 (2017).","journal-title":"Front. Med."},{"key":"1258_CR120","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jac\/dkx374","volume":"73","author":"U Malik","year":"2018","unstructured":"Malik, U. et al. Association between prior antibiotic therapy and subsequent risk of community-acquired infections: a systematic review. J. Antimicrob. Chemother. 73, 287\u2013296 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"1258_CR121","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad413","volume":"10","author":"AC Miller","year":"2023","unstructured":"Miller, A. C. et al. Comparison of different antibiotics and the risk for community-associated Clostridioides difficile infection: a case\u2013control study. Open. Forum Infect. Dis. 10, ofad413 (2023).","journal-title":"Open. Forum Infect. Dis."},{"key":"1258_CR122","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41579-023-00933-y","volume":"21","author":"SRS Fishbein","year":"2023","unstructured":"Fishbein, S. R. S., Mahmud, B. & Dantas, G. Antibiotic perturbations to the gut microbiome. Nat. Rev. Microbiol. 21, 772\u2013788 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR123","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41579-023-00936-9","volume":"21","author":"L de Nies","year":"2023","unstructured":"de Nies, L., Kobras, C. M. & Stracy, M. Antibiotic-induced collateral damage to the microbiota and associated infections. Nat. Rev. Microbiol. 21, 789\u2013804 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1258_CR124","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.eclinm.2024.102428","volume":"68","author":"H Huang","year":"2024","unstructured":"Huang, H., Jiang, J., Wang, X., Jiang, K. & Cao, H. Exposure to prescribed medication in early life and impacts on gut microbiota and disease development. eClinicalMedicine 68, 102428 (2024).","journal-title":"eClinicalMedicine"},{"key":"1258_CR125","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cmet.2023.12.027","volume":"36","author":"J She","year":"2024","unstructured":"She, J. et al. Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner. Cell Metab. 36, 408\u2013421.e5 (2024).","journal-title":"Cell Metab."},{"key":"1258_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1346-1","volume":"17","author":"T Bretler","year":"2019","unstructured":"Bretler, T., Weisberg, H., Koren, O. & Neuman, H. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. BMC Med. 17, 112 (2019).","journal-title":"BMC Med."},{"key":"1258_CR127","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2023.06.004","volume":"95","author":"L Michaelis","year":"2023","unstructured":"Michaelis, L., Berg, L. & Maier, L. Confounder or confederate? The interactions between drugs and the gut microbiome in psychiatric and neurological diseases. Biol. Psychiatry 95, 361\u2013369 (2023).","journal-title":"Biol. Psychiatry"},{"key":"1258_CR128","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.chom.2024.04.018","volume":"32","author":"JB Simpson","year":"2024","unstructured":"Simpson, J. B. et al. Gut microbial \u03b2-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Cell Host Microbe 32, 925\u2013944.e10 (2024).","journal-title":"Cell Host Microbe"},{"key":"1258_CR129","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","volume":"581","author":"S Vieira-Silva","year":"2020","unstructured":"Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310\u2013315 (2020).","journal-title":"Nature"},{"key":"1258_CR130","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1210\/endrev\/bnad029","volume":"45","author":"M Rosell-D\u00edaz","year":"2024","unstructured":"Rosell-D\u00edaz, M. & Fern\u00e1ndez-Real, J. M. Metformin, cognitive function, and changes in the gut microbiome. Endocr. Rev. 45, 210\u2013226 (2024).","journal-title":"Endocr. Rev."},{"key":"1258_CR131","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33953","volume":"7","author":"N Koppel","year":"2018","unstructured":"Koppel, N., Bisanz, J. E., Pandelia, M.-E., Turnbaugh, P. J. & Balskus, E. P. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. eLife 7, e33953 (2018).","journal-title":"eLife"},{"key":"1258_CR132","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium eggerthella lenta. Science 341, 295\u2013298 (2013).","journal-title":"Science"},{"key":"1258_CR133","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831\u2013835 (2010).","journal-title":"Science"},{"key":"1258_CR134","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.chembiol.2015.08.005","volume":"22","author":"BD Wallace","year":"2015","unstructured":"Wallace, B. D. et al. Structure and inhibition of microbiome \u03b2-glucuronidases essential to the alleviation of cancer drug toxicity. Chem. Biol. 22, 1238\u20131249 (2015).","journal-title":"Chem. Biol."},{"key":"1258_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 310 (2019).","journal-title":"Nat. Commun."},{"key":"1258_CR136","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J. & Balskus, E. P. Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science 364, eaau6323 (2019).","journal-title":"Science"},{"key":"1258_CR137","doi-asserted-by":"publisher","first-page":"e2443","DOI":"10.1212\/WNL.0000000000201204","volume":"99","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Association between microbial tyrosine decarboxylase gene and levodopa responsiveness in patients with Parkinson disease. Neurology 99, e2443\u2013e2453 (2022).","journal-title":"Neurology"},{"key":"1258_CR138","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s42255-023-00796-w","volume":"5","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. Inactivation of the antidiabetic drug acarbose by human intestinal microbial-mediated degradation. Nat. Metab. 5, 896\u2013909 (2023).","journal-title":"Nat. Metab."},{"key":"1258_CR139","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04091-0","volume":"600","author":"J Balaich","year":"2021","unstructured":"Balaich, J. et al. The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature 600, 110\u2013115 (2021).","journal-title":"Nature"},{"key":"1258_CR140","first-page":"e01679","volume":"16","author":"Y Alam","year":"2024","unstructured":"Alam, Y. et al. Variation in human gut microbiota impacts tamoxifen pharmacokinetics. mBio 16, e01679-24 (2024).","journal-title":"mBio"},{"key":"1258_CR141","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","volume":"29","author":"RS Mehta","year":"2023","unstructured":"Mehta, R. S. et al. Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nat. Med. 29, 700\u2013709 (2023).","journal-title":"Nat. Med."},{"key":"1258_CR142","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41586-024-07754-w","volume":"632","author":"B Roje","year":"2024","unstructured":"Roje, B. et al. Gut microbiota carcinogen metabolism causes distal tissue tumours. Nature 632, 1137\u20131144 (2024).","journal-title":"Nature"},{"key":"1258_CR143","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/bph.16020","volume":"180","author":"J Meng","year":"2023","unstructured":"Meng, J. et al. Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model. Br. J. Pharmacol. 180, 1362\u20131378 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"1258_CR144","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.mucimm.2024.03.007","volume":"17","author":"LF Mager","year":"2024","unstructured":"Mager, L. F., Krause, T. & McCoy, K. D. Interaction of microbiota, mucosal malignancies, and immunotherapy \u2014 mechanistic insights. Mucosal Immunol. 17, 402\u2013415 (2024).","journal-title":"Mucosal Immunol."},{"key":"1258_CR145","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"1258_CR146","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager, L. F. et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369, 1481\u20131489 (2020).","journal-title":"Science"},{"key":"1258_CR147","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He, Y. et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 33, 988\u20131000.e7 (2021).","journal-title":"Cell Metab."},{"key":"1258_CR148","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot, J. et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615, 168\u2013174 (2023).","journal-title":"Nature"},{"key":"1258_CR149","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/j.gastro.2025.04.025","volume":"169","author":"LA Bolte","year":"2025","unstructured":"Bolte, L. A., Bj\u00f6rk, J. R., Gacesa, R. & Weersma, R. K. Pharmacomicrobiomics: the role of the gut microbiome in immunomodulation and cancer therapy. Gastroenterology 169, 813\u2013827 (2025).","journal-title":"Gastroenterology"},{"key":"1258_CR150","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.cell.2023.05.007","volume":"186","author":"CL Nguyen","year":"2023","unstructured":"Nguyen, C. L. et al. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell 186, 2705\u20132718.e17 (2023).","journal-title":"Cell"},{"key":"1258_CR151","doi-asserted-by":"publisher","first-page":"e00102","DOI":"10.1128\/jb.00102-22","volume":"204","author":"Y Kyono","year":"2022","unstructured":"Kyono, Y. et al. The atypical antipsychotic quetiapine promotes multiple antibiotic resistance in Escherichia coli. J. Bacteriol. 204, e00102\u2013e00122 (2022).","journal-title":"J. Bacteriol."},{"key":"1258_CR152","first-page":"e02191","volume":"13","author":"J Ou","year":"2022","unstructured":"Ou, J. et al. TCA and SSRI antidepressants exert selection pressure for efflux-dependent antibiotic resistance mechanisms in Escherichia coli. mBio 13, e02191-22 (2022).","journal-title":"Escherichia coli. mBio"},{"key":"1258_CR153","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208344120","volume":"120","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Antidepressants can induce mutation and enhance persistence toward multiple antibiotics. Proc. Natl Acad. Sci. USA 120, e2208344120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1258_CR154","doi-asserted-by":"publisher","first-page":"ycae123","DOI":"10.1093\/ismeco\/ycae123","volume":"4","author":"C Dop","year":"2024","unstructured":"Dop, C., Auvin, S., Mondot, S., Lepage, P. & Ilhan, Z. E. Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape. ISME Commun. 4, ycae123 (2024).","journal-title":"ISME Commun."},{"key":"1258_CR155","first-page":"e03804","volume":"12","author":"Y Kyono","year":"2023","unstructured":"Kyono, Y., Magboo, J. D., Daley, E. A. & Flowers, S. A. Antipsychotic quetiapine alters the mouse fecal resistome by impacting antibiotic efflux, cell membrane, and cell wall synthesis genes. Microbiol. Spectr. 12, e03804\u2013e03823 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1258_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01314-y","volume":"10","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Non-antibiotic pharmaceuticals promote conjugative plasmid transfer at a community-wide level. Microbiome 10, 124 (2022).","journal-title":"Microbiome"},{"key":"1258_CR157","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/1040841X.2023.2233603","volume":"50","author":"I Alav","year":"2024","unstructured":"Alav, I. & Buckner, M. M. C. Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes. Crit. Rev. Microbiol. 50, 993\u20131010 (2024).","journal-title":"Crit. Rev. Microbiol."},{"key":"1258_CR158","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1111\/1462-2920.16165","volume":"24","author":"P Ding","year":"2022","unstructured":"Ding, P., Lu, J., Wang, Y., Schembri, M. A. & Guo, J. Antidepressants promote the spread of antibiotic resistance via horizontally conjugative gene transfer. Environ. Microbiol. 24, 5261\u20135276 (2022).","journal-title":"Environ. Microbiol."},{"key":"1258_CR159","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2514138","volume":"17","author":"P Ding","year":"2025","unstructured":"Ding, P. et al. Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota. Gut Microbes 17, 2514138 (2025).","journal-title":"Gut Microbes"},{"key":"1258_CR160","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41396-018-0275-x","volume":"13","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Antiepileptic drug carbamazepine promotes horizontal transfer of plasmid-borne multi-antibiotic resistance genes within and across bacterial genera. ISME J. 13, 509\u2013522 (2019).","journal-title":"ISME J."},{"key":"1258_CR161","doi-asserted-by":"publisher","first-page":"2157698","DOI":"10.1080\/19490976.2022.2157698","volume":"15","author":"Z Yu","year":"2023","unstructured":"Yu, Z., Henderson, I. R. & Guo, J. Non-caloric artificial sweeteners modulate conjugative transfer of multi-drug resistance plasmid in the gut microbiota. Gut Microbes 15, 2157698 (2023).","journal-title":"Gut Microbes"},{"key":"1258_CR162","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chom.2020.02.002","volume":"27","author":"A Domenech","year":"2020","unstructured":"Domenech, A. et al. Proton motive force disruptors block bacterial competence and horizontal gene transfer. Cell Host Microbe 27, 544\u2013555.e3 (2020).","journal-title":"Cell Host Microbe"},{"key":"1258_CR163","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.cell.2025.12.051","volume":"189","author":"CY Kim","year":"2026","unstructured":"Kim, C. Y. et al. Planetary microbiome structure and generalist-driven gene flow across disparate habitats. Cell 189, 2073\u20132091.e21 (2026).","journal-title":"Cell"},{"key":"1258_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28464-9","volume":"13","author":"O Aasmets","year":"2022","unstructured":"Aasmets, O., Krigul, K. L., L\u00fcll, K., Metspalu, A. & Org, E. Gut metagenome associations with extensive digital health data in a volunteer-based Estonian microbiome cohort. Nat. Commun. 13, 869 (2022).","journal-title":"Nat. Commun."},{"key":"1258_CR165","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.copbio.2025.103338","volume":"95","author":"K Petersen","year":"2025","unstructured":"Petersen, K. & Mansell, T. J. Unveiling the prebiotic potential of polyphenols in gut health and metabolism. Curr. Opin. Biotechnol. 95, 103338 (2025).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1258_CR166","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.cell.2018.05.008","volume":"173","author":"C Tropini","year":"2018","unstructured":"Tropini, C. et al. Transient osmotic perturbation causes long-term alteration to the gut microbiota. Cell 173, 1742\u20131754.e17 (2018).","journal-title":"Cell"},{"key":"1258_CR167","doi-asserted-by":"publisher","first-page":"102517","DOI":"10.1016\/j.xcrm.2025.102517","volume":"7","author":"CA Clayton","year":"2025","unstructured":"Clayton, C. A. et al. In mouse and in vitro models, bowel preparation promotes pathogen colonization, translocation, and exacerbation of inflammation. Cell Rep. Med. 7, 102517 (2025).","journal-title":"Cell Rep. Med."},{"key":"1258_CR168","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5946\/ce.2024.147","volume":"58","author":"HH Jo","year":"2024","unstructured":"Jo, H. H., Lee, M. Y., Ha, S. E., Yeom, D. H. & Kim, Y. S. Alteration in gut microbiota after colonoscopy: proposed mechanisms and the role of probiotic interventions. Clin. Endosc. 58, 25\u201339 (2024).","journal-title":"Clin. Endosc."},{"key":"1258_CR169","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1946368","volume":"13","author":"A Cruz-Lebr\u00f3n","year":"2021","unstructured":"Cruz-Lebr\u00f3n, A. et al. Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity. Gut Microbes 13, 1946368 (2021).","journal-title":"Gut Microbes"},{"key":"1258_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76570-9","volume":"10","author":"RE Gicquelais","year":"2020","unstructured":"Gicquelais, R. E., Bohnert, A. S. B., Thomas, L. & Foxman, B. Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment. Sci. Rep. 10, 19471 (2020).","journal-title":"Sci. Rep."},{"key":"1258_CR171","first-page":"e00957","volume":"9","author":"A Lopez-Moreno","year":"2024","unstructured":"Lopez-Moreno, A. et al. Bisphenol A exposure affects specific gut taxa and drives microbiota dynamics in childhood obesity. mSystems 9, e00957-23 (2024).","journal-title":"mSystems"},{"key":"1258_CR172","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40793-020-00371-w","volume":"16","author":"G Lear","year":"2021","unstructured":"Lear, G. et al. Plastics and the microbiome: impacts and solutions. Environ. Microbiome 16, 2 (2021).","journal-title":"Environ. Microbiome"},{"key":"1258_CR173","doi-asserted-by":"publisher","unstructured":"Hillege, L. E. et al. Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.10.11.24315249 (2024).","DOI":"10.1101\/2024.10.11.24315249"},{"key":"1258_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00996-6","volume":"9","author":"S Naimi","year":"2021","unstructured":"Naimi, S., Viennois, E., Gewirtz, A. T. & Chassaing, B. Direct impact of commonly used dietary emulsifiers on human gut microbiota. Microbiome 9, 66 (2021).","journal-title":"Microbiome"},{"key":"1258_CR175","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/gutjnl-2016-313099","volume":"66","author":"B Chassaing","year":"2017","unstructured":"Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M. & Gewirtz, A. T. Dietary emulsifiers directly alter human microbiota composition and gene expression ex\u00a0vivo potentiating intestinal inflammation. Gut 66, 1414\u20131427 (2017).","journal-title":"Gut"},{"key":"1258_CR176","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/rheumatology\/keac458","volume":"62","author":"J Qiao","year":"2023","unstructured":"Qiao, J. et al. Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis. Rheumatology 62, 1087\u20131096 (2023).","journal-title":"Rheumatology"},{"key":"1258_CR177","doi-asserted-by":"publisher","unstructured":"Villa Soto, V. S. et al. The gut microbiome shapes pharmacology and treatment outcomes for a key anti-inflammatory therapy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.26.661733 (2025).","DOI":"10.1101\/2025.06.26.661733"},{"key":"1258_CR178","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S1568-7864(02)00147-7","volume":"1","author":"R Bhattacharya","year":"2002","unstructured":"Bhattacharya, R. & Beck, D. J. Survival and SOS induction in cisplatin-treated Escherichia coli deficient in Pol II, RecBCD and RecFOR functions. DNA Repair 1, 955\u2013966 (2002).","journal-title":"DNA Repair"},{"key":"1258_CR179","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/ja.2010.64","volume":"63","author":"K Joyce","year":"2010","unstructured":"Joyce, K. et al. Antimicrobial spectrum of the antitumor agent, cisplatin. J. Antibiot. 63, 530\u2013532 (2010).","journal-title":"J. Antibiot."},{"key":"1258_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02814-5","volume":"19","author":"S Gong","year":"2021","unstructured":"Gong, S. et al. Gut microbiota accelerates cisplatin-induced acute liver injury associated with robust inflammation and oxidative stress in mice. J. Transl. Med. 19, 147 (2021).","journal-title":"J. Transl. Med."},{"key":"1258_CR181","doi-asserted-by":"publisher","first-page":"1217306","DOI":"10.3389\/fphar.2023.1217306","volume":"14","author":"L Tian","year":"2023","unstructured":"Tian, L. et al. Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota. Front. Pharmacol. 14, 1217306 (2023).","journal-title":"Front. Pharmacol."},{"key":"1258_CR182","doi-asserted-by":"publisher","first-page":"102567","DOI":"10.1016\/j.sbi.2023.102567","volume":"80","author":"MA Beliaeva","year":"2023","unstructured":"Beliaeva, M. A., Wilmanns, M. & Zimmermann, M. Decipher enzymes from human microbiota for drug discovery and development. Curr. Opin. Struct. Biol. 80, 102567 (2023).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1258_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010029","volume":"18","author":"V Periwal","year":"2022","unstructured":"Periwal, V. et al. Bioactivity assessment of natural compounds using machine learning models trained on target similarity between drugs. PLoS Comput. Biol. 18, e1010029 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"1258_CR184","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42866","volume":"8","author":"L Guthrie","year":"2019","unstructured":"Guthrie, L., Wolfson, S. & Kelly, L. The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. eLife 8, e42866 (2019).","journal-title":"eLife"},{"key":"1258_CR185","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tibtech.2014.01.005","volume":"32","author":"M Kl\u00fcnemann","year":"2014","unstructured":"Kl\u00fcnemann, M., Schmid, M. & Patil, K. R. Computational tools for modeling xenometabolism of the human gut microbiota. Trends Biotechnol. 32, 157\u2013165 (2014).","journal-title":"Trends Biotechnol."},{"key":"1258_CR186","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41587-022-01628-0","volume":"41","author":"A Heinken","year":"2023","unstructured":"Heinken, A. et al. Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nat. Biotechnol. 41, 1320\u20131331 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1258_CR187","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41596-023-00926-4","volume":"19","author":"P M\u00fcller","year":"2024","unstructured":"M\u00fcller, P. et al. High-throughput anaerobic screening for identifying compounds acting against gut bacteria in monocultures or communities. Nat. Protoc. 19, 668\u2013699 (2024).","journal-title":"Nat. Protoc."},{"key":"1258_CR188","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2021.12.008","volume":"30","author":"A Aranda-D\u00edaz","year":"2022","unstructured":"Aranda-D\u00edaz, A. et al. Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota. Cell Host Microbe 30, 260\u2013272.e5 (2022).","journal-title":"Cell Host Microbe"},{"key":"1258_CR189","doi-asserted-by":"publisher","DOI":"10.1093\/ismeco\/ycae035","volume":"4","author":"JN Z\u00fcnd","year":"2024","unstructured":"Z\u00fcnd, J. N. et al. A flexible high-throughput cultivation protocol to assess the response of individuals\u2019 gut microbiota to diet-, drug-, and host-related factors. ISME Commun. 4, ycae035 (2024).","journal-title":"ISME Commun."},{"key":"1258_CR190","doi-asserted-by":"publisher","first-page":"828359","DOI":"10.3389\/fmicb.2022.828359","volume":"13","author":"A El Houari","year":"2022","unstructured":"El Houari, A. et al. Development of an in vitro model of human gut microbiota for screening the reciprocal interactions with antibiotics, drugs, and xenobiotics. Front. Microbiol. 13, 828359 (2022).","journal-title":"Front. Microbiol."},{"key":"1258_CR191","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coisb.2017.05.020","volume":"4","author":"E Cacace","year":"2017","unstructured":"Cacace, E., Kritikos, G. & Typas, A. Chemical genetics in drug discovery. Curr. Opin. Syst. Biol. 4, 35\u201342 (2017).","journal-title":"Curr. Opin. Syst. Biol."},{"key":"1258_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108789","volume":"34","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments. Cell Rep. 34, 108789 (2021).","journal-title":"Cell Rep."},{"key":"1258_CR193","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202311525","volume":"19","author":"S Wuyts","year":"2023","unstructured":"Wuyts, S. et al. Consistency across multi-omics layers in a drug-perturbed gut microbial community. Mol. Syst. Biol. 19, e11525 (2023).","journal-title":"Mol. Syst. Biol."},{"key":"1258_CR194","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3973","volume":"10","author":"M Zampieri","year":"2018","unstructured":"Zampieri, M. et al. High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds. Sci. Transl. Med. 10, eaal3973 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1258_CR195","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41596-022-00771-x","volume":"18","author":"L Malinovska","year":"2023","unstructured":"Malinovska, L. et al. Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications. Nat. Protoc. 18, 659\u2013682 (2023).","journal-title":"Nat. Protoc."},{"key":"1258_CR196","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188242","volume":"14","author":"A Mateus","year":"2018","unstructured":"Mateus, A. et al. Thermal proteome profiling in bacteria: probing protein state in vivo. Mol. Syst. Biol. 14, e8242 (2018).","journal-title":"Mol. Syst. Biol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01258-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:04:16Z","timestamp":1789380256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-026-01258-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":196,"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1038\/s41575-026-01258-w","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"24 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.R.P. is a co-founder and Director of Cambiotics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}